Parallel SFC: A Faster Approach to Chiral Column Screening

April 16, 2026

Introduction

Supercritical fluid chromatography (SFC) is increasingly utilized for the separation and purification of optical isomers (chiral compounds) due to its advantages over high-performance liquid chromatography (HPLC), including faster analysis times, reduced consumption of organic solvents, and simplified post-processing. SFC systems enable rapid identification of optimal separation conditions through automated variation of column chemistries (column screening) and modifier solvent compositions, facilitating efficient chiral separations at the analytical scale. Once suitable conditions are established, methods can be readily scaled up for preparative purification. Since SFC is faster and more environmentally friendly compared to HPLC, it has been widely adopted in pharmaceutical drug discovery, particularly in response to increasingly stringent regulations governing the use and disposal of organic solvents

There are two primary approaches used for column screening in SFC. In the first approach, the desired column is selected by switching valves positioned before and after the column. In the second approach, a parallel screening method is employed in which the flow path is divided at a manifold, allowing the mobile phase and the sample to be delivered simultaneously to multiple columns. This parallel configuration enables concurrent analyses, significantly reducing overall screening time. In this application note, we demonstrate the separation of flavanone, a chiral compound, using the parallel SFC system.

Experimental

Instruments

CO2 pump:                      PU-4386

Modifier pump:              PU-4086*

Heater:                            HE-02

Heater controller:          HC-4068-01

Autosampler:                 AS-4350

Column oven:                 CO-4060*

UV dectector:                 UV-4075* x 4

BP regulator:                  BP-4340

*with option units

SFC Conditions

Column:                           CHIRALPAK IA, IB, IC, ID* (4.6 mm I.D. x 150 mm L, 5 µm)

Eluent A:                          Carbon dioxide

Eluent B:                          Acetonitrile, methanol

Flow rate:                        Eluent A; 8.0 mL/min, Eluent B; 3.0 mL/min

Column temp:                40 ºC

Wavelength:                   250 nm

Back pressure:              15 MPa

Injection volume:          10 µL

Sample:                          1 mg/mL flavanone in MeOH

*CHIRALPAK is a trademark or registered mark of Daicel Corporation.

Fig. 1 Structure of Flavanone
Fig. 2 Schematic diagram of SFC system

Keywords

SFC, supercritical fluid chromatography, Chiral compounds, Column screening, CHIRALPAK, UV detector

Results

Figure 3 shows chromatograms of flavanone obtained using the parallel SFC system. Acetonitrile and methanol were evaluated as modifier solvents, and both achieved baseline separation within 4 minutes. The results indicate that, with both solvents, racemic flavanone can be successfully resolved on CHIRALPAK IA and CHIRALPAK ID columns.

On the CHIRALPAK IA column, shorter retention times were observed with acetonitrile compared to methanol, whereas the opposite trend was observed on the CHIRALPAK ID column. The reproducibility of retention times and peak areas for both columns and modifier solvents is summarized in Tables 1 to 4.

For comparison, performing the same analyses using the column-switching method required approximately 46 minutes to obtain four chromatograms, including column equilibration time. In contrast, the parallel method reduced total analysis time by more than an order of magnitude. Furthermore, although only two modifier solvents were evaluated in this study, expanding the number of solvents (up to ten) would further enhance the time-saving advantages of the parallel screening approach over conventional column switching.

Fig. 3 Chromatograms of flavanone obtained using the parallel SFC system (at UV 250 nm)

Table 1. Reproducibility of measurement results obtained using parallel SFC system (modifier solvent: acetonitrile, column: CHIRALPAK IA)

Injection NumberFlavanone 1Flavanone 1Flavanone 2Flavanone 2
tR [min]Peak AreatR [min]Peak Area
11.6271,232,8072.0461,232,651
21.6331,258,1902.0451,248,113
31.6171,241,8832.0291,240,881
41.6241,241,4762.0391,230,797
51.6271,258,1812.0401,246,964
Average1.6261,246,5072.0401,239,881
SD0.00510,0710.0067,124
RSD [%]0.3200.8080.2960.575

Table 2. Reproducibility of measurement results obtained using parallel SFC system (modifier solvent: acetonitrile, column: CHIRALPAK ID)

Injection NumberFlavanone 1Flavanone 1Flavanone 2Flavanone 2
tR [min]Peak AreatR [min]Peak Area
12.1771,231,3843.3091,231,448
22.1761,255,5213.2881,253,962
32.1571,238,7883.2611,241,872
42.1651,241,1123.2881,245,737
52.1631,247,8163.2751,254,756
Average2.1681,242,9243.2841,245,555
SD0.0088,2000.0168,578
RSD [%]0.3570.6600.4850.689

Table 3. Reproducibility of measurement results obtained using parallel SFC system (modifier solvent: methanol, column: CHIRALPAK IA)

Injection NumberFlavanone 1
Flavanone 1
Flavanone 2
Flavanone 2
tR [min]
Peak AreatR [min]
Peak Area
11.7821,272,3802.5311,270,850
21.7971,266,3722.5531,272,041
31.7871,262,6032.5381,264,940
41.7881,249,7512.5451,253,775
51.7971,256,1982.5541,263,684
Average1.7901,261,4612.5441,265,058
SD0.0067,8670.0096,504
RSD [%]
0.3300.6240.3460.514

Table 4. Reproducibility of measurement results obtained using parallel SFC system (modifier solvent: methanol, column: CHIRALPAK ID)

Injection NumberFlavanone 1
Flavanone 1
Flavanone 2
Flavanone 2
tR [min]
Peak AreatR [min]
Peak Area
11.9951,240,478
3.026
1,244,109
22.0101,251,4133.0451,253,958
32.0001,238,2163.0281,241,664
42.0001,218,7743.0351,234,367
52.0101,236,8753.0421,241,633
Average2.0031,237,1513.0351,243,146
SD0.00610,5200.0076,315
RSD [%]
0.3000.8500.2460.508
This document has been prepared based on information available at the time of publication and is subject to revision without notice. Although the contents are checked with the utmost care, we do not guarantee their accuracy or completeness. JASCO Corporation assumes no responsibility or liability for any loss or damage incurred as a result of the use of any information contained in this document. Copyright and other intellectual property rights in this document remain the property of JASCO Corporation. Please do not attempt to copy, modify, redistribute, or sell etc. in whole or in part without prior written permission.